Monte Rosa Therapeutics, Inc. (GLUE)
$10.30-0.19%Close
SELLCRISIS · day 50
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $870M
- Beta
- 1.37
- P/E (TTM)
- -4.53
- Short % float
- 32.94%
- Days to cover
- 18.0
- SI change
- +2.2%
- 1W
- -1.90%
- 1M
- -28.07%
- vs SPY 1W
- -3.07%
- vs SPY 1M
- -31.06%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GLUE?
- LOPJLB’s latest quantitative signal on Monte Rosa Therapeutics, Inc. (GLUE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is GLUE in?
- Monte Rosa Therapeutics, Inc. (GLUE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Monte Rosa Therapeutics, Inc. (GLUE) do?
- Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins. Among their key initiatives is an oral molecular glue degrader designed to target GSPT1, a specific translational termination factor and deg…